CTC Research by Cytona’s CEO Featured on a News Program

Research on circulating tumor cells (CTCs) conducted by Cytona’s CEO, Takashi Ohnaga, has been featured on a Japanese news program.
https://news.ntv.co.jp/n/knb/category/life/kn60d2984134a0491186149c2502705a56